Transgene SA (EPA:TNG)
France · Delayed Price · Currency is EUR 0.7270
-0.0010 (-0.14%)
Nov 12, 2026, 9:00 AM CET
Transgene Market Cap
Transgene has a market cap or net worth of €199.11 million as of November 11, 2026. It is the 19,902nd most valuable company in the world and the 243rd biggest in France. Its market cap has increased by 21.79% in one year.
Market Cap
199.11M
Enterprise Value
108.45M
Revenue
5.62M
Global Rank
Country Rank
#243 France
PE Ratio
n/a
ChartMarket Cap Chart
Since March 30, 1998, Transgene's market cap has increased from 151.86M to 199.11M, an increase of 31.12%. That is a compound annual growth rate of 0.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 199.11M | -24.26% |
| Dec 31, 2025 | 262.87M | 192.89% |
| Dec 31, 2024 | 89.75M | -34.86% |
| Dec 29, 2023 | 137.78M | -16.38% |
| Dec 30, 2022 | 164.76M | -33.52% |
| Dec 31, 2021 | 247.84M | 79.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inventiva | 793.90M |
| DBV Technologies | 630.29M |
| Genfit | 531.33M |
| Valneva SE | 492.95M |
| Valerio Therapeutics Société anonyme | 237.24M |
| Innate Pharma | 123.68M |
| Sensorion | 83.06M |
| Cellectis | 76.26M |